Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00805428

Enrollment

Registered

2008-12-09

Start date

2008-09-30

Completion date

Unknown

Last updated

2008-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Brief summary

Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* endoscopic confirmed diagnosis

Exclusion criteria

* corticosteroid or immunosuppressive therapy

Countries

Croatia

Contacts

Primary ContactJasna Ajdukovic, MSc

jasna.ajdukovic@gmail.com0917983374

Outcome results